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Sequence variantsAbstract Next-generation sequencing (NGS) is getting routinely used in the diagnosis of hereditary
diseases, such as human cardiomyopathies. Hence, it is of utter importance to secure high quality
sequencing data, enabling the identification of disease-relevant mutations or the conclusion of neg-
ative test results. During the process of sample preparation, each protocol for target enrichment
library preparation has its own requirements for quality control (QC); however, there is little evi-
dence on the actual impact of these guidelines on resulting data quality. In this study, we analyzed
the impact of QC during the diverse library preparation steps of Agilent SureSelect XT target
enrichment and Illumina sequencing. We quantified the parameters for a cohort of around 600 sam-
ples, which include starting amount of DNA, amount of sheared DNA, smallest and largest frag-
ment size of the starting DNA; amount of DNA after the pre-PCR, and smallest and largest
fragment size of the resulting DNA; as well as the amount of the final library, the correspondingnces and
Nietsch R et al /NGS Quality Control 201smallest and largest fragment size, and the number of detected variants. Intriguingly, there is a high
tolerance for variations in all QC steps, meaning that within the boundaries proposed in the current
study, a considerable variance at each step of QC can be well tolerated without compromising NGS
quality.Introduction
Before the advent of next-generation sequencing (NGS),
genetic testing was realized by Sanger sequencing [1], which
meant analyzing a gene exon-wise or amplicon-wise in a
relatively elaborate, time-consuming and costly way. This sub-
stantially limited the number of genes that could be examined
in parallel. In 2005, the first commercial NGS systems were
introduced, yielding up to 20 megabase (mb) output per run
[2]. Genetic studies have gained enormously from NGS over
the past years. There is no doubt that NGS has matured to
a technique that is highly reliable if performed by following
certain rules [3]. Today, it is to replace Sanger sequencing
not only in research, but also in clinical applications. One
major step in this path is the first marketing authorization
for an NGS instrument (Illumina’s MiSeqDx) by the Food
and Drug Administration of the United States (US FDA)
[4]. Besides such optimism, less certainty exists on the required
standards for ensuring sequencing quality. It is also debated
whether precise bench-work or careful data analysis is more
important. For gene panel or target enrichment, a number of
distinct protocols based on, e.g., PCR, hybridization, or selec-
tive circularization, have been developed [5]. For each of these
methods, stringent quality control (QC) steps were introduced
to ensure a consistent data quality of the resulting NGS pro-
cess. On the other hand, QC is expensive and requires signifi-
cant hands-on time. Moreover, it is virtually unknown how
QC could affect the sequencing process in case of abnormal
results obtained.
With respect to the influence of data analysis on sequence
quality, numerous studies and recommendations provide a
guideline toward reproducible and comparable NGS results
[6]. This so-called post-sequencing QC typically starts with
raw-data processing covering measures of base quality, nucleo-
tide distribution, GC content distribution, and read duplica-
tion rate. Then post-alignment QC is mostly based on the
BAM-files, which provides QC parameters like the number
of mappable reads, mapping quality, depth of coverage, and
the number of reads mapped to the target region. Finally, on
the variant level, data quality can be analyzed by the transi-
tion/transversion (Ti/Tv) ratio, heterozygosity rate, or occur-
rence in variant databases [3].
In this study, we investigated, using a large-scale dataset
from nearly 600 patients, the impact of the many different
QC phases during library preparation on the resulting sequenc-
ing data, and provided a recommendation on library quality
requirement.
Results and discussion
Impact of library preparation on NGS quality
While it is broadly appreciated that post-processing of
sequencing data is inevitable, less certainty exists on theinfluence of wet-lab steps during library preparation on the
final quality of variant calls. Hence, we collected data from
stringent QC during a larger-scale diagnostic target-
enrichment study, which has underlined the high analytical
quality and feasibility of NGS in a clinical genetic diagnostic
setting [3].
Our aim in the current study was to investigate whether
sequencing results are affected by quality differences during
the library preparation. We thus tested if QC during the
diverse library preparation protocol can foresee any impact
on the quality of the resulting sequencing library. To do so,
we first examined the statistical distributions of all assessed
QC parameters over a set of 581 patient samples undergoing
SureSelect target enrichment (referred as ‘‘main cohort” here-
after). The QC steps examined include initial DNA-shearing
and cleanup (QC1), pre-PCR and clean-up (QC2), as well as
post-PCR and clean-up (QC3). Figure 1 depicts Violin plots
of the distributions of the following parameters at each QC
step: DNA concentration, largest fragment size, and smallest
fragment size, which are all approximately normal.
Then we tested by Pearson correlation, as well as Spearman
and Kendall, whether the aforementioned parameters mea-
sured at different steps of the library preparation protocol
exert significant impact on the quality of the resulting sequenc-
ing library. Surprisingly, we did not find any obvious correla-
tion between the different QC steps and library QC measures,
all correlation coefficients were below 0.4 (Figure 2). Next, we
calculated linear correlations of the different QC steps with the
total number of detected sequence variants as an indicator of
final sequence quality. The lower triangular part of the matrix
in Figure 2A shows the absolute values of the Pearson correla-
tion coefficients between every possible pair of parameters,
whereas the upper triangular part shows the scatter plots. Fig-
ure 2B shows the absolute values of the Spearman correlation
coefficients below the diagonal and the absolute values of the
Kendall correlation coefficients above the diagonal. Again,
we did not detect obvious correlations.
Robustness of library preparation for NGS
To further underline these findings, we applied Mann–Whitney
U-test and Sze´kely’s distance correlation on the total number
of variant calls to rule out the possibility of undetected corre-
lation in outliers and dependency of variant calls. As shown in
Figure 1, the horizontal red bars indicate the total number of
variant calls on the top 10% of the study population for each
parameter and the blue bars on the bottom 10%, respectively.
At QC1, the numbers of variant calls differ significantly
between the bottom 10% population and top 10% population
in terms of the smallest fragment size obtained (P= 0.04;
U-test). According to Sze´kely’s distance correlation coefficients
(Table 1), there is a weak dependency between the smallest
fragment size and number of variant calls at QC1
(R= 0.25), whereas the distance correlation coefficients are
consistently less than 0.2 for the remaining parameters. This
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Figure 1 QC-parameter distribution
The violin plots depict the distribution of parameters concentration (ng/ll; A), smallest fragment length (bp; B), and largest fragment
length (bp; C), at the three steps of enrichment and library preparation QC1, QC2, and QC3. The number of total variant calls for the top
10% of each parameter is plotted as the red horizontal bar or as blue horizontal bar for the bottom 10%, and then compared using t-test.
Significant difference (P< 0.05) between number of total variant calls for the top 10% and those for the bottom 10% of each parameter is
indicated by asterisk (*).
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independent from the parameters at all three QC steps. These
data demonstrate that except the smallest fragment size at
QC1, our indicator of sequence quality does not correlate well
to the QC parameters. Even in the 10% populations at both
extremes, no statistically significant influence of QC parame-
ters on the final datasets has been observed.
To further examine the dependency between number of
variant calls and smallest fragment size at QC1, we analyzed
11 samples that were previously excluded from the sequencing
study due to aberrant QC parameters (referred as ‘‘extra
cohort” hereafter). Figure 3 exemplarily shows that the extra
cohort differs significantly from our main cohort in the num-
ber of total variants, the smallest fragment size at QC1, and
concentration at QC3 (P< 0.001; t-test). By combining the
extra cohort with our main cohort, the coefficients of distance
correlation fluctuate by up to |DR| = 0.03 (Table 1). In partic-
ular, the coefficient between QC1 smallest fragment size and
total variants goes up from 0.25 to 0.28. U-test significance
on the 10% extremes also becomes greater with P value
reduced from 0.04 to 0.003, indicating that total variants
depend on the smallest fragment size at QC1. To exclude a
population effect on the number of total variants detected in
the main and the extra cohorts, we selected from our European
cohort only those samples having the same geographic back-
ground (n= 69) for correlation analysis. As a result, we
observed a visible Pearson correlation (R= 0.61) between
QC1 smallest fragment size and number of total variants
(Figure 4). In particular, we observe that when QC1 smallest
fragment size goes below 80 bp, the total variant count falls
below its population stratum from the main cohort and
fluctuates widely.
Conclusion
The presented data indicate that the target enrichment proto-
col adopted in this study in combination with 2  100 bp
sequencing by synthesis (HiSeq2000, Illumina) technologyseems mostly affected by the initial QC and the smallest frag-
ment size (<80 bp). Our data highlight the importance of a
high quality input DNA and careful evaluation of the QC1
step (Figure 4). The fact that the 10% extreme tests at QC2
and QC3 steps are not affected by the extra cohort (Figure 1)
suggests that the later stages of library preparation have good
tolerances toward variations in quality. One might argue that
sequence quality is more than the number of variants called,
which was used as the surrogate of final data quality in this
study. Although this is a potential limitation of the current
study, the number of called variants still provides a robust
overall assessment and is a good indicator of abnormalities
in sequence data [7–9].
In summary, we postulate that a considerable variance in
QC during target enrichment and library preparation is well
tolerated within the boundaries indicated above (DNA after
QC1 > 80 bp).Material and methods
Data source
We used QC and sequencing data from a large-scale target
enrichment sequencing study, lately performed by us [3].
Detailed information on the design of the 0.5 mb sized target
region, hybridization-based target enrichment (SureSelect),
2  100 bp sequencing process (Illumina, HiSeq 2000), and
data analysis can be found in the supplements of our previous
report [3].
Quality control
The quality of DNA library is tested at three major steps dur-
ing the library preparation protocol. This is to ensure that the
modifications of the DNA molecules introduced in the preced-
ing step are successful and that enough material is left for the
following modification steps. The first QC step ensures that the
AFigure 2 QC-correlation analysis
The diagonal of the 10  10 matrix shows the histogram of total variants for the independent measurements of concentration, largest
fragment length, and smallest fragment length at 3 QC steps (QC1, QC2, and QC 3). The lower triangular part of the matrix displays the
absolute value of the Pearson correlation coefficients between the pair of parameters (A). The lower triangular part displays the absolute
value of the Spearman correlation coefficients and the upper triangular part displays the Kendall correlation coefficients (B). Strong
correlations are indicated with larger font sizes, while smaller fonts are used for weak correlations. The upper triangular part of the matrix
displays the scatter plots between the pair of parameters, together with a best-fit line (red). The parameter shown on the x-axis of the
scatter plot is given below inside the diagonal, and that on the y-axis is given leftward inside the diagonal. Correlation coefficient ranges 0–
1 (no linear correlation: 0–0.5; weak correlation: 0.5–0.8; strong correlation: 0.8–1).
Nietsch R et al /NGS Quality Control 203DNA is sheared at the right size and that enough DNA is left
after a first cleanup with Ampure XP beads. The second QC
step ensures that a successful adapter ligation is achieved
and sufficient adapter-ligated DNA remained for the upcom-
ing hybridization. The third QC step verifies that enough
DNA is retained from the hybridization and amplification
steps in a second PCR and that the size of the resulting final
library is in the optimum range for paired-end sequencing.
Parameters that are quantified from readings of the Bio-
analyzer (DNA 1000 assay) (Agilent; Waldbronn, Germany)
platform include amount of sheared DNA and the smallest
and largest fragment size of the sheared DNA; the amountof DNA after the pre-PCR and the smallest and largest frag-
ment sizes of the resulting DNA; as well as the amount of final
library and the smallest and largest fragment size of remaining
DNA. QC was performed after the initial DNA-shearing and
cleanup (QC1), after the pre-PCR and clean-up (QC2), and
from the final library after post-PCR and clean-up (QC3).
Statistical analysis
To examine the correlation between parameters, Pearson,
Spearman, and Kendall correlation coefficients were com-
puted for each pair of parameters. U-test [10] was
BFigure 2 (continued)
Table 1 Szekely’s distance correlation coefﬁcients in relation to total variants at different QC steps
Parameters Distance correlation coeﬃcients P value D coeﬃcient with extra cohort
QC1 Largest fragment size (bp) 0.11 <0.05 0.03
Concentration (ng/ll) 0.10 <0.05 0.01
Smallest fragment size (bp) 0.25 <0.01 0.03
QC2 Largest fragment size (bp) 0.07 =0.325 0
Concentration (ng/ll) 0.15 <0.05 0
Smallest fragment size (bp) 0.19 <0.01 0.03
QC3 Largest fragment size (bp) 0.15 <0.01 0.02
Concentration (ng/ll) 0.15 <0.01 0.03
Smallest fragment size (bp) 0.15 <0.01 0.01
Note: Distance correlation coefficient is zero if and only if the variable pair is independent.
204 Genomics Proteomics Bioinformatics 14 (2016) 200–206performed on the number of variant calls for the top 10%
and bottom 10% outliers for each parameter. Distance
correlation was computed to determine independencies
between the parameters [11] using ‘dcor’ command in
package ‘energy’ [12]. Distance correlation coefficient is zeroif and only if the variables are completely independent.
t-test was performed between the main cohort and
extra cohort. All computations are carried out in R
(version 3.2). For distance correlation, ‘dcor’ command in
package ‘energy’ was used [12].
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Figure 4 Pearson correlation of QC1 fragment size and total variants
The scatter plot of QC1 smallest fragment size vs. number of total variant calls is shown. The red dots represent the extra cohort, while the
blue dots represent main cohort samples who share the same geographic background as the extra cohort. The gray line is the best-fit line
(Pearson correlation; R= 0.61; P< 0.001). The extra cohort has QC1 smallest fragment size less than 80 bp showing large deviation in
number of total variants.
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Figure 3 Comparison of study cohorts
The boxplots illustrate the difference between the main cohort and extra cohort in terms of number of total variant calls (A), QC1 smallest
fragment size (B), and QC3 concentration (C), respectively. Significant difference between main cohort and extra cohort is indicated with
asterisks (P< 0.001, t-test).
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